663 related articles for article (PubMed ID: 27184586)
1. Complex bifurcation lesions: Randomized comparison of a fully bioresorbable modified t stenting strategy versus bifurcation reconstruction with a dedicated self-expanding stent in combination with bioresorbable scaffolds, an OCT study: Rationale and design of the COBRA II trial.
Bennett J; Adriaenssens T; Desmet W; Dubois C
Catheter Cardiovasc Interv; 2016 Nov; 88(6):843-853. PubMed ID: 27184586
[TBL] [Abstract][Full Text] [Related]
2. The COBRA II (COmplex Bifurcation lesions: RAndomized comparison of a fully bioresorbable modified-T stenting strategy versus bifurcation reconstruction with a dedicated self-expanding stent in combination with bioresorbable scaffolds) study: Final 5-year follow-up.
Bennett J; Desmet W; Dubois C
Indian Heart J; 2023; 75(6):473-476. PubMed ID: 37739221
[TBL] [Abstract][Full Text] [Related]
3. COmplex Bifurcation Lesions: RAndomized Comparison of Modified-T Stenting vs Reconstruction With Self-Expanding Stent and Bioresorbable Scaffold: COBRA II.
Bennett J; McCutcheon K; Vanhaverbeke M; Pauwels R; Adriaenssens T; Sinnaeve P; Desmet W; Dubois C
J Invasive Cardiol; 2021 Apr; 33(4):E281-E293. PubMed ID: 33723086
[TBL] [Abstract][Full Text] [Related]
4. 5-Year clinical follow-up of the COBRA (complex coronary bifurcation lesions: Randomized comparison of a strategy using a dedicated self-expanding biolimus A9-eluting stent vs. a culotte strategy using everolimus-eluting stents) study.
Bennett J; Adriaenssens T; McCutcheon K; Dens J; Desmet W; Sinnaeve P; Vrolix M; Dubois C
Catheter Cardiovasc Interv; 2018 Nov; 92(6):E375-E380. PubMed ID: 29536609
[TBL] [Abstract][Full Text] [Related]
5. Comparison of acute expansion of bioresorbable vascular scaffolds versus metallic drug-eluting stents in different degrees of calcification: An Optical Coherence Tomography Study.
Ming Fam J; van Der Sijde JN; Karanasos A; Felix C; Diletti R; van Mieghem N; de Jaegere P; Zijlstra F; Jan van Geuns R; Regar E
Catheter Cardiovasc Interv; 2017 Apr; 89(5):798-810. PubMed ID: 27717119
[TBL] [Abstract][Full Text] [Related]
6. COmplex coronary Bifurcation lesions: RAndomized comparison of a strategy using a dedicated self-expanding biolimus-eluting stent versus a culotte strategy using everolimus-eluting stents: primary results of the COBRA trial.
Dubois C; Bennett J; Dens J; De Cock D; Desmet W; Belmans A; Ughi GJ; Sinnaeve P; Vrolix M; D'hooge J; Adriaenssens T
EuroIntervention; 2016 Apr; 11(13):1457-67. PubMed ID: 25947278
[TBL] [Abstract][Full Text] [Related]
7. Healing responses after bifurcation stenting with the dedicated TRYTON Side-Branch Stent™ in combination with XIENCE-V™ stents: a clinical, angiography, fractional flow reserve, and optical coherence tomography study: the PYTON (Prospective evaluation of the TRYTON Side-Branch Stent™ with an additional XIENCE-v™ everolimus-eluting stent in coronary bifurcation lesions) study.
Dubois C; Adriaenssens T; Ughi G; Wiyono S; Bennett J; Coosemans M; Ferdinande B; Sinnaeve P; D'hooge J; Desmet W
Catheter Cardiovasc Interv; 2013 Feb; 81(3):E155-64. PubMed ID: 22745031
[TBL] [Abstract][Full Text] [Related]
8. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
[TBL] [Abstract][Full Text] [Related]
9. Comparison of sirolimus eluting stent with bioresorbable polymer to everolimus eluting stent with permanent polymer in bifurcation lesions: Results from CENTURY II trial.
Orvin K; Carrie D; Richardt G; Desmet W; Assali A; Werner G; Ikari Y; Fujii K; Goicolea J; Dangoisse V; Manari A; Saito S; Wijns W; Kornowski R
Catheter Cardiovasc Interv; 2016 May; 87(6):1092-100. PubMed ID: 26268482
[TBL] [Abstract][Full Text] [Related]
10. Mid-term clinical outcomes of ABSORB bioresorbable vascular scaffold versus everolimus-eluting stent for coronary bifurcation lesions.
Naganuma T; Kawamoto H; Panoulas VF; Latib A; Tanaka A; Mitomo S; Ruparelia N; Jabbour RJ; Chieffo A; Carlino M; Montorfano M; Colombo A
Int J Cardiol; 2017 Nov; 246():26-31. PubMed ID: 28867010
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes following bifurcation double-stenting with bioresorbable scaffolds.
Tanaka A; Latib A; Kawamoto H; Jabbour RJ; Mangieri A; Pagnesi M; Montalto C; Regazzoli D; Ancona M; Chieffo A; Carlino M; Montorfano M; Colombo A
Catheter Cardiovasc Interv; 2016 Nov; 88(6):854-862. PubMed ID: 27184769
[TBL] [Abstract][Full Text] [Related]
12. Impact of strut thickness on acute mechanical performance: A comparison study using optical coherence tomography between DESolve 150 and DESolve 100.
Boeder NF; Dörr O; Bauer T; Mattesini A; Elsässer A; Liebetrau C; Achenbach S; Hamm CW; Nef HM
Int J Cardiol; 2017 Nov; 246():74-79. PubMed ID: 28579164
[TBL] [Abstract][Full Text] [Related]
13. ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: rationale and study design.
Diletti R; Serruys PW; Farooq V; Sudhir K; Dorange C; Miquel-Hebert K; Veldhof S; Rapoza R; Onuma Y; Garcia-Garcia HM; Chevalier B
Am Heart J; 2012 Nov; 164(5):654-63. PubMed ID: 23137495
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes.
Serruys PW; Onuma Y; Ormiston JA; de Bruyne B; Regar E; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Miquel-Hebert K; Rapoza R; García-García HM
Circulation; 2010 Nov; 122(22):2301-12. PubMed ID: 21098436
[TBL] [Abstract][Full Text] [Related]
15. Baseline and 9 months IVUS analysis of the bifurcation-dedicated biolimus A9-eluting Axxess stent system: the DIVERGE IVUS substudy.
Buysschaert I; Sanidas E; Hasegawa T; Koo BK; Honda Y; Fitzgerald PJ; Verheye S
Catheter Cardiovasc Interv; 2014 Dec; 84(7):1062-70. PubMed ID: 24478226
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes after percutaneous revascularization of complex coronary bifurcation lesions using a dedicated self-expanding biolimus-eluting stent system.
Triantafyllis AS; Bennett J; Pagourelias E; McCutcheon K; Adriaenssens T; Sinnaeve PR; Desmet W; Dubois C
Cardiol J; 2018; 25(4):470-478. PubMed ID: 29240962
[TBL] [Abstract][Full Text] [Related]
17. In vitro mechanical behavior and in vivo healing response of a novel thin-strut ultrahigh molecular weight poly-l-lactic acid sirolimus-eluting bioresorbable coronary scaffold in normal swine.
Cheng Y; Gasior P; Ramzipoor K; Lee C; McGregor JC; Conditt GB; McAndrew T; Kaluza GL; Granada JF
Int J Cardiol; 2019 Jul; 286():21-28. PubMed ID: 30967275
[TBL] [Abstract][Full Text] [Related]
18. The absorb bioresorbable vascular scaffold in coronary bifurcations: insights from bench testing.
Džavík V; Colombo A
JACC Cardiovasc Interv; 2014 Jan; 7(1):81-8. PubMed ID: 24332424
[TBL] [Abstract][Full Text] [Related]
19. Differences in Vessel Healing Between Sirolimus- and Everolimus-Eluting Stent Implantation for Bifurcation Lesions: The J-REVERSE Optical Coherence Tomography Substudy.
Terashita D; Otake H; Shinke T; Murasato Y; Kinoshita Y; Yamawaki M; Takeda Y; Fujii K; Yamada S; Shimada Y; Yamashita T; Yumoto K; Hirata K
Can J Cardiol; 2016 Mar; 32(3):384-90. PubMed ID: 26481078
[TBL] [Abstract][Full Text] [Related]
20. Bioresorbable magnesium scaffold in the treatment of simple coronary bifurcation lesions: The BIFSORB pilot II study.
Barkholt TØ; Neghabat O; Holck EN; Andreasen LN; Christiansen EH; Holm NR
Catheter Cardiovasc Interv; 2022 Mar; 99(4):1075-1083. PubMed ID: 34967094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]